ALKEM - Technical Analysis with Chart Patterns & Indicators
Last Updated Time : 20 Dec 25, 03:54 pm
Back to Technical ListTechnical Rating: 3.4
| Stock Code | ALKEM | Market Cap | 66,424 Cr. | Current Price | 5,556 ₹ | High / Low | 5,868 ₹ |
| Stock P/E | 29.7 | Book Value | 1,143 ₹ | Dividend Yield | 0.82 % | ROCE | 19.5 % |
| ROE | 19.9 % | Face Value | 2.00 ₹ | DMA 50 | 5,592 ₹ | DMA 200 | 5,349 ₹ |
| Chg in FII Hold | 0.36 % | Chg in DII Hold | 0.13 % | PAT Qtr | 724 Cr. | PAT Prev Qtr | 610 Cr. |
| RSI | 39.6 | MACD | -8.99 | Volume | 35,179 | Avg Vol 1Wk | 47,102 |
| Low price | 4,492 ₹ | High price | 5,868 ₹ | PEG Ratio | 2.13 | Debt to equity | 0.06 |
| 52w Index | 77.3 % | Qtr Profit Var | 12.8 % | EPS | 204 ₹ | Industry PE | 30.6 |
📊 Chart Patterns: ALKEM is trading slightly below its 50 DMA (5,592 ₹) but above its 200 DMA (5,349 ₹), showing mixed signals. Current price (5,556 ₹) is near short-term support at 5,500–5,520 ₹, with resistance around 5,592–5,650 ₹ and major resistance at 5,868 ₹.
📈 Moving Averages: Price above the 200 DMA indicates long-term strength, but failure to hold above the 50 DMA suggests short-term weakness.
📉 RSI: At 39.6, RSI is approaching oversold territory, hinting at potential for a bounce.
📉 MACD: Negative at -8.99, confirming bearish momentum in the short term.
📊 Bollinger Bands: Price is near the lower band, indicating oversold conditions and possible mean reversion.
📊 Volume Trends: Current volume (35,179) is lower than average weekly volume (47,102), suggesting reduced participation and cautious sentiment.
📌 Momentum Signals: Short-term bounce possible from 5,500–5,520 ₹ support, but trend remains weak unless price sustains above 5,592–5,650 ₹.
🎯 Entry Zone: 5,500–5,556 ₹ (near support, oversold RSI).
🎯 Exit Zone: 5,592–5,650 ₹ (short-term resistance), extended resistance at 5,868 ₹.
🔎 Trend Status: Currently consolidating with bearish bias. Reversal requires breakout above 5,650–5,868 ₹.
Positive
- Strong ROCE (19.5%) and ROE (19.9%) indicate efficient capital use.
- Debt-to-equity ratio of 0.06 shows a healthy balance sheet.
- Quarterly PAT improved (724 Cr. vs 610 Cr.), reflecting growth momentum.
- EPS of 204 ₹ supports strong earnings base.
Limitation
- RSI near oversold levels indicates weak momentum.
- MACD negative, confirming short-term bearishness.
- Stock P/E (29.7) is close to industry PE (30.6), offering limited valuation advantage.
Company Negative News
- Stock struggling to stay above 50 DMA, reflecting short-term weakness.
- Volume participation lower than average, showing cautious investor sentiment.
Company Positive News
- Quarterly profit growth (+12.8%) shows operational improvement.
- Dividend yield of 0.82% adds shareholder value.
- FII (+0.36%) and DII (+0.13%) holdings increased, reflecting institutional confidence.
Industry
- Industry PE at 30.6 is slightly higher than ALKEM’s P/E (29.7), suggesting fair valuation.
- Pharmaceutical sector outlook remains strong with consistent demand drivers.
Conclusion
⚖️ ALKEM is consolidating near support with weak short-term momentum but strong long-term fundamentals. Traders may consider entry around 5,500–5,556 ₹ with exit near 5,592–5,650 ₹. Long-term investors can hold for extended targets near 5,868 ₹, while monitoring RSI and MACD for reversal confirmation.
Back to Technical ListNIFTY 50 - Today Top Technical Picks Stock Picks
NEXT 50 - Today Top Technical Picks Stock Picks
MIDCAP - Today Top Technical Picks Stock Picks
SMALLCAP - Today Top Technical Picks Stock Picks